Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia
· Delayed Price · Currency is AUD 0.250
0.00 (0.00%)
Mar 10, 2026, 10:39 AM AEST
ASX:PAR Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -36.09 | -18.77 | -58.73 | -51.91 | -39.25 | -34.3 | Upgrade
|
| Depreciation & Amortization | 0.15 | 0.15 | 0.15 | 0.15 | 0.19 | 0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.53 | 2.53 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.24 | 0.1 | 1.2 | 0.94 | 3.27 | 3.21 | Upgrade
|
| Other Operating Activities | 1.08 | -0.11 | 0.05 | 0.3 | -0.86 | -0.31 | Upgrade
|
| Change in Accounts Receivable | 0.06 | -0.29 | 1.36 | 0.36 | 1.79 | -5.05 | Upgrade
|
| Change in Accounts Payable | 3.91 | -0.09 | -9.34 | 5.07 | 2.1 | 2.2 | Upgrade
|
| Change in Other Net Operating Assets | 0.68 | 0.48 | -0.63 | -0.1 | 0.54 | -0.89 | Upgrade
|
| Operating Cash Flow | -27.42 | -15.99 | -65.94 | -45.19 | -32.21 | -34.93 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.03 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.5 | - | - | - | - | -0 | Upgrade
|
| Investment in Securities | -0.07 | 0.05 | - | - | - | 0.7 | Upgrade
|
| Investing Cash Flow | -0.57 | 0.05 | - | - | - | 0.67 | Upgrade
|
| Long-Term Debt Repaid | - | -0.13 | -0.1 | -0.1 | -0.14 | -0.12 | Upgrade
|
| Total Debt Repaid | -0.13 | -0.13 | -0.1 | -0.1 | -0.14 | -0.12 | Upgrade
|
| Net Debt Issued (Repaid) | 18.22 | -0.13 | -0.1 | -0.1 | -0.14 | -0.12 | Upgrade
|
| Issuance of Common Stock | 0.08 | 16 | 30.12 | 66.4 | 0.21 | 1.12 | Upgrade
|
| Other Financing Activities | -0.13 | -0.88 | -1.84 | -3.76 | - | - | Upgrade
|
| Financing Cash Flow | 18.17 | 14.99 | 28.18 | 62.53 | 0.07 | 1 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.3 | -0.05 | -0.74 | -0.69 | 0.77 | 0.37 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | -10.12 | -1 | -38.51 | 16.66 | -31.36 | -32.89 | Upgrade
|
| Free Cash Flow | -27.42 | -15.99 | -65.94 | -45.19 | -32.21 | -34.96 | Upgrade
|
| Free Cash Flow Margin | -324524.20% | - | - | - | -40650.90% | -170122.95% | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.05 | -0.23 | -0.18 | -0.14 | -0.15 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | Upgrade
|
| Cash Income Tax Paid | - | -6.3 | -7.33 | -7.4 | -9.53 | -3.37 | Upgrade
|
| Levered Free Cash Flow | -17.95 | -14.29 | -49.02 | -31.18 | -22.04 | -27.37 | Upgrade
|
| Unlevered Free Cash Flow | -17.12 | -14.29 | -49.01 | -31.17 | -22.02 | -27.34 | Upgrade
|
| Change in Working Capital | 4.65 | 0.1 | -8.61 | 5.33 | 4.44 | -3.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.